Aytu biopharma holds fiscal 2026 q3 earnings call

13. mai 2026

Rapportert av AI

Aytu BioPharma conducted its earnings call for the fiscal 2026 third quarter on May 13, 2026. Executives discussed operational and financial results for the period ended March 31, 2026.

The conference call began at 4:30 PM EDT with an introduction from investor relations representative Robert Blum of Lytham Partners. Chief Executive Officer Joshua Disbrow and Chief Financial Officer Ryan J. Selhorn joined to review company performance. Analysts from firms including Lake Street Capital Markets and Ascendiant Capital Markets participated in the session.

Relaterte artikler

Cytek Biosciences holds first quarter 2026 earnings call

Cytek Biosciences released its financial results for the first quarter of 2026 on May 7. The company then hosted an earnings conference call the same day at 4:30 PM EDT.

Nuvation Bio holds Q1 2026 earnings call

4. mai 2026 Rapportert av AI

Nuvation Bio Inc. conducted its first quarter 2026 earnings call on May 4, 2026. The company reviewed financial results for the period ending March 31, 2026, and provided a business update. Executives including CEO David Hung participated in the discussion.

Teknologi

Ceva holds first quarter 2026 earnings conference call

Næringsliv

Cryoport announces Q4 2025 earnings call

Teknologi

Atlassian holds Q3 2026 earnings call

Adaptive Biotechnologies holds Q1 2026 earnings call

Adaptive Biotechnologies Corporation conducted its first quarter 2026 earnings conference call on May 5, 2026, at 4:30 PM EDT. Company executives, including CEO Chad Robins and CFO Kyle Piskel, presented financial results and forward-looking statements. The call is available via webcast on the company's investor relations website.